S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.
Inhibitors of apoptosis (IAPs) are a family of highly-conserved proteins that regulate cell survival through binding to caspases, the final executioners of apoptosis. X-linked IAP (XIAP) is the most widely expressed IAP and plays an important function in regulating cell survival. XIAP contains 3 baculoviral IAP repeats (BIRs) followed by a RING finger domain at the C terminal. The BIR domains of XIAP possess anticaspase activities, whereas the RING finger domain enables XIAP to function as an E3 ubiquitin ligase in the ubiquitin and proteasomal system. Our previous study showed that parkin, a protein that is important for the survival of dopaminergic neurons in Parkinson's disease (PD), is S-nitrosylated both in vitro and in vivo in PD patients. S-nitrosylation of parkin compromises its ubiquitin E3 ligase activity and its protective function, which suggests that nitrosative stress is an important factor in regulating neuronal survival during the pathogenesis of PD. In this study we show that XIAP is S-nitrosylated in vitro and in vivo in an animal model of PD and in PD patients. Nitric oxide modifies mainly cysteine residues within the BIR domains. In contrast to parkin, S-nitrosylation of XIAP does not affect its E3 ligase activity, but instead directly compromises its anticaspase-3 and antiapoptotic function. Our results confirm that nitrosative stress contributes to PD pathogenesis through the impairment of prosurvival proteins such as parkin and XIAP through different mechanisms, indicating that abnormal S-nitrosylation plays an important role in the process of neurodegeneration.
Tsang
Anthony H K
AH
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong.
Lee
Yun-Il
YI
Ko
Han Seok
HS
Savitt
Joseph M
JM
Pletnikova
Olga
O
Troncoso
Juan C
JC
Dawson
Valina L
VL
Dawson
Ted M
TM
Chung
Kenny K K
KK
D000818:Animals; D017209:Apoptosis; D061945:Caspase Inhibitors; D002470:Cell Survival; D019610:Cytoprotection; D004195:Disease Models, Animal; D004789:Enzyme Activation; D006801:Humans; D051379:Mice; D009474:Neurons / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D009569:Nitric Oxide / Q000378:metabolism; D009603:Nitroso Compounds / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology*; D055503:Protein Multimerization; D017434:Protein Structure, Tertiary; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000378:metabolism*
D061945:Caspase Inhibitors; D009603:Nitroso Compounds; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human; D009569:Nitric Oxide; D044767:Ubiquitin-Protein Ligases